CCG-222740
CAS No. 1922098-69-8
CCG-222740( —— )
Catalog No. M21055 CAS No. 1922098-69-8
CCG-222740 is an inhibitor of Rho/MRTF pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 61 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 96 | In Stock |
|
| 25MG | 181 | In Stock |
|
| 50MG | 269 | In Stock |
|
| 100MG | 384 | In Stock |
|
| 200MG | 548 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCCG-222740
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCG-222740 is an inhibitor of Rho/MRTF pathway.
-
DescriptionCCG-222740 is an inhibitor of Rho/MRTF pathway.
-
In VitroCell Cycle Analysis Cell Line:Cancer associated fibroblasts (CAFs) Concentration:10, 20 μM Incubation Time:72 hours Result:Increased the protein levels of p27 and decreased cyclin D1.
-
In VivoAnimal Model:KC mice (LSL-KrasG12D/+; Pdx-1-Cre) of age at 9 weeks Dosage:100?mg/kg Administration:Oral gavage; daily; for 7 days Result:Reduced α-SMA levels in the pancreas of caerulein-stimulated KC mice.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetRho
-
RecptorRho
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1922098-69-8
-
Formula Weight444.86
-
Molecular FormulaC23H19ClF2N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL?(280.99 Mm)
-
SMILESO=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccco3)c2)CC(F)(F)C1
-
Chemical NameN-(4-chlorophenyl)-55-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
ITX3
ITX3 is a specific, non-toxic, active and selective TrioN RhoGEF inhibitor with IC50 of 76 μM. ITX3 has anticancer effects, inhibits trion mediated GTP exchange on RhoG and Rac1, inhibits NGF-mediated neurite growth in PC12 cells and REF52 fibroblast structure formation induced by trion.
-
CCG-257081
CCG-257081 (MRTF/SRF-IN-1) is an inhibitor of cardiac myosin-related transcription factor and serum response factor (MRTF/SRF) that acts by inhibiting the Rho/MRTF/SRF pathway.CCG-257081 has shown efficacy in preventing bleomycin-induced fibrosis in several mouse models.
-
SAR407899
SAR407899 is Rho kinase inhibitor potently inhibits endothelin-1-induced constriction of renal resistance arteries.
Cart
sales@molnova.com